Allessandra Quevedo discusses the heightened levels of risk exposure spanning across the entire technological infrastructure connected to the pharmaceutical industry, from research and manufacturing, and from distribution and hospitals. Companies in the pharmaceutical industry contain increasingly growing (and massive) bodies of sensitive data, including proprietary information related to products as well as consumer healthcare information. Therefore, it is imperative that companies adapt systems and processes to making sure their proprietary and sensitive data remains secure and accessible from emerging cybersecurity threats.
Read MoreIntellectual Property
Cybersecurity in the U.S. Private Security
Mark Tchao discusses how incentivizing companies to invest in top cybersecurity measures in the profit-driven market continues to be a challenge. Government compliance can be illusory, but without decisive changes in the landscape of matters, things may only get worse.
Read MoreInnovation and Litigation
Uma Joshi provides an overview of intellectual property perspectives in literature, and contributes a focused discussion of the landmark Apple vs. Samsung patent trial of 2011.
Read More3D Printing and the Future of Intellectual Property
Carolyn Tweedy provides a brief background of 3D printing and contributes a focused discussion of the implications of 3D printing technologies in the world of information management and intellectual property, specifically copyright and patent laws and the development of policies to govern this burgeoning domain.
Read MoreRisk Themes for America's Defense Industrial Base Sector
This research note outlines three major categorical risk themes and includes assessments and treatment suggestions for each category.
Read More